Mov Disord Vol 31, Suppl 2 Archives - Page 143 of 207 - MDS Abstracts

2016 International Congress
Botulinum toxin in cerebral palsy children with gait disorder: Different therapy approaches
G.S. Pilina (Izhevsk, Russia)
Objective: The purpose of this work was to study the effectiveness of different therapy approaches with Botulinum toxin type A (BTX-A) in Cerebral Palsy (CP)…
2016 International Congress
Sensor-based motor state detection in Parkinson’s disease to approach personalized therapy delivery
L.P. Roncoroni, M. Scholten, I. Hanci, A. Gharabagi, D. Weiss (Tübingen, Germany)
Objective: As primary objective, we acquire a data pool of medically-treated PD patients with motor fluctuations to determine the sensitivity and specificity of algorithms capable…
2016 International Congress
RE-024: Mechanism of action and efficacy in non-clinical models
M. Beconi, E. Monteagudo, A. Di Marco, S. Malancona, D. Elbaum, S. Harper (San Diego, CA, USA)
Objective: To confirm the mechanism of action of RE-024, and evaluate its activity in human cellular models and brain penetration in animal models. Background: Pantothenate…
2016 International Congress
Effects of subthalamic deep brain stimulation in motor and nonmotor function in Parkinson’s disease patients with parkin mutation
L.M. Oliveira, R.G. Cury, H.F. Chien, J.G. Santos, M.G. Ghilardi, R.B. Machado, E.T. Fonoff, B.R. Egberto (São Paulo, Brazil)
Objective: The aim of our study was to evaluate prospectively the changes in motor, nonmotor symptoms (NMS) and quality of life produced by subthalamic deep…
2016 International Congress
Toward clinical use of electrode localizations in deep brain stimulation therapy
S. Ewert, A. Horn, P. Plettig, M. Ruch, A. Kühn (Berlin, Germany)
Objective: To develop an open source software capable of performing electrode localizations certified for clinical use in deep brain stimulation therapy. Background: Deep brain stimulation…
2016 International Congress
Longitudinal changes of speech and voice disorders following subthalamic stimulation in Parkinson’s disease patients
T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, K. Kawabata, K. Hara, M. Ito, M. Hirayama, Y. Fujimoto, Y. Kajita, M. Katsuno, G. Sobue (Nagoya, Japan)
Objective: To elucidate longitudinal changes of speech and voice disorders in Parkinson's disease (PD) patients treated with subthalamic nucleus deep brain stimulation (STN-DBS). Background: Previously,…
2016 International Congress
Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease
P. Poortvliet, A. Fytagoridis, T. Coyne, P. Silburn (Brisbane, Australia)
Objective: The aim of this study is to validate practical and objective measures to assess changes in rigidity and tremor due to micro-lesion effects and…
2016 International Congress
Cortical and subcortical contribution in the production of reaching movements in Parkinson’s disease
A. Canessa, N.G. Pozzi, G. Arnulfo, J. Brumberg, F. Steigerwald, M.F. Ghilardi, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)
Objective: To investigate the interplay between subthalamic nucleus (STN) activity and striatal dopamine deficiency in the production of arm movements in subjects with Parkinson's disease…
2016 International Congress
Is awake intraoperative mapping still necessary for bilateral subthalamic stimulation for Parkinson’s disease in a modern surgical environment?
Y. Zouitina, M. Lefranc, P. Merle, O. Godefroy, M. Tir, P. Krystkowiak (Amiens, France)
Objective: To study the impact of the absence of awake clinical evaluation during subthalamic nucleus (STN) deep brain stimulation (DBS) on parameters of stimulation and…
2016 International Congress
Cognitive change following deep brain stimulation in patients with movement disorders
J. Khan, Z. Quamhawi, Y.F. Tai, P.G. Bain, D. Nandi, S. Gunning, N. Pavese (London, United Kingdom)
Objective: To assess the degree and pattern of cognitive changes following Deep Brain Stimulation (DBS) in patients with Parkinson's disease (PD), Dystonia and Essential Tremor…